Connective tissue growth factor and integrin αvβ6: A new pair of regulators critical for ductular reaction and biliary fibrosis in mice

Hepatology

Volumn 61, Issue 2, 2015, Pages 678-691

  Pi, Liya ^a   Robinson, Paulette M ^a   Jorgensen, Marda ^a   Oh, Seh Hoon ^a   Brown, Alicia R ^a   Weinreb, Paul H ^c   Trinh, Thu Le ^a   Yianni, Protopapadakis ^a   Liu, Chen ^a   Leask, Andrew ^b   Violette, Shelia M ^c   Scott, Edward W ^a   Schultz, Gregory S ^a   Petersen, Bryon E ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b WESTERN UNIVERSITY   (Canada)

^c BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; ALPHA SMOOTH MUSCLE ACTIN; ALPHAVBETA6 INTEGRIN; BIOLOGICAL MARKER; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; CRE RECOMBINASE; CYTOKERATIN 19; EPITHELIAL CELL ADHESION MOLECULE; FIBRONECTIN; GREEN FLUORESCENT PROTEIN; HYDROXYPROLINE; MESSENGER RNA; NEUTRALIZING ANTIBODY; NEUTRALIZING ANTIBODY 6.3G9; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; 3,5-DIETHOXYCARBONYL-1,4-DIHYDROCOLLIDINE; INTEGRIN; PYRIDINE DERIVATIVE; TGFB1 PROTEIN, RAT; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CHOLESTASIS; COLLAGEN SYNTHESIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CTGF GENE; EXON; EXTRACELLULAR MATRIX; GENE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER FIBROSIS; LIVER INJURY; LOXP SITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIRIUS RED STAINING; STAINING; ADULT STEM CELL; ANIMAL; BILE DUCT CARCINOMA; BILE DUCT TUMOR; FEMALE; INTRAHEPATIC BILE DUCT; KNOCKOUT MOUSE; LIVER CIRRHOSIS; MALE; METABOLISM; RABBIT; RAT; TOXIC HEPATITIS;

ADULT STEM CELLS; ANIMALS; ANTIGENS, NEOPLASM; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL ADHESION; CHOLANGIOCARCINOMA; CONNECTIVE TISSUE GROWTH FACTOR; DRUG-INDUCED LIVER INJURY; FEMALE; FIBRONECTINS; HUMANS; INTEGRINS; LIVER CIRRHOSIS; MALE; MICE; MICE, KNOCKOUT; PYRIDINES; RABBITS; RATS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84921522273     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27425     Document Type: Article

References (28)

1. Williams MJ, Clouston AD, Forbes SJ. Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology 2014;146:349-356.
2. Gouw AS, Clouston AD, Theise ND. Ductular reactions in human liver: diversity at the interface. Hepatology 2011;54:1853-1863.
3. Sempoux C, Fan C, Singh P, Obeidat K, Roayaie S, Schwartz M, et al. Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. Semin Liver Dis 2011;31:104-110.
4. Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005;41:809-818.
5. Nguyen LN, Furuya MH, Wolfraim LA, Nguyen AP, Holdren MS, Campbell JS, et al. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology 2007;45:31-41.
6. Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, et al. TWEAK induces liver progenitor cell proliferation. J Clin Invest 2005;115:2330-2340.
7. Gressner OA, Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 2008;28:1065-1079.
8. Tong Z, Chen R, Alt DS, Kemper S, Perbal B, Brigstock DR. Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology 2009;50:939-947.
9. Pi L, Ding X, Jorgensen M, Pan JJ, Oh SH, Pintilie D, et al. Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation. Hepatology 2008;47:996-1004.
10. Huang G, Brigstock DR. Integrin expression and function in the response of primary culture hepatic stellate cells to connective tissue growth factor (CCN2). J Cell Mol Med 2011;15:1087-1095.
11. Pi L, Shenoy AK, Liu J, Kim S, Nelson N, Xia H, et al. CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB J 2012;26:3365-3379.
12. Abreu JG, Ketpura NI, Reversade B, De Robertis EM. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 2002;4:599-604.
13. Pi L, Oh SH, Shupe T, Petersen BE. Role of connective tissue growth factor in oval cell response during liver regeneration after 2-AAF/PHx in rats. Gastroenterology 2005;128:2077-2088.
14. Fontana L, Chen Y, Prijatelj P, Sakai T, Fässler R, Sakai LY, Rifkin DB. Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J 2005;19:1798-1808.
15. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319-328.
16. Van Aarsen LA, Leone DR, Ho S, Dolinski BM, McCoon PE, LePage DJ, et al. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Cancer Res 2008;68:561-570.
17. Patsenker E, Popov Y, Stickel F, Jonczyk A, Goodman SL, Schuppan D. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology 2008;135:660-670.
18. Wang B, Dolinski BM, Kikuchi N, Leone DR, Peters MG, Weinreb PH, et al. Role of alphavbeta6 integrin in acute biliary fibrosis. Hepatology 2007;46(5):1404-1412.
19. Popov Y, Patsenker E, Stickel F, Zaks J, Bhaskar KR, Niedobitek G, et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol 2008;48:453-464.
20. Weinreb PH, Simon KJ, Rayhorn P, Yang WJ, Leone DR, Dolinski BM, et al. Function-blocking integrin alphavbeta6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes. J Biol Chem 2004;279:17875-17887.
21. Gibson DJ, Pi L, Sriram S, Mao C, Petersen BE, Scott EW, et al. Conditional knockout of CTGF affects corneal wound healing. Invest Ophthalmol Vis Sci 2014;55:2062-2070.
22. Liu S, Shi-wen X, Abraham DJ, Leask A. CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum 2011;63:239-246.
23. Patsenker E, Wilkens L, Banz V, Osterreicher CH, Weimann R, Eisele S, et al. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma. J Hepatol 2010;52:362-369.
24. Fickert P, Stöger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, et al. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 2007;171:525-536.
25. Tong ZY, Brigstock DR. Intrinsic biological activity of the thrombospondin structural homology repeat in connective tissue growth factor. J Endocrinol 2006;188:R1-R8.
26. Leask A, Liu S. CCN2 is not required for skin development. J Cell Commun Signal 2011;5:179-182.
27. Geng H, Lan R, Singha PK, Gilchrist A, Weinreb PH, Violette SM, et al. Lysophosphatidic acid increases proximal tubule cell secretion of profibrotic cytokines PDGF-B and CTGF through LPA2- and Gαq-mediated Rho and αvβ6 integrin-dependent activation of TGF-β. Am J Pathol 2012;181:1236-1249.
28. Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest 2013;123:1887-1901.